High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the trk receptors

被引:62
作者
Urfer, R [1 ]
Tsoulfas, P
O'Connell, L
Hongo, JA
Zhao, W
Presta, LG
机构
[1] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[2] Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33135 USA
[3] Univ Miami, Sch Med, Miami Project, Miami, FL 33135 USA
关键词
D O I
10.1074/jbc.273.10.5829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurotrophic factors are important for survival and maintenance of neurons during developmental and adult stages of the vertebrate nervous system. The neurotrophins mediate their signal into the cell by specific interaction with tyrosine kinase receptors of the Trk family, The extracellular immunoglobulin-like domain of the Trk receptors adjacent to the membrane has previously been shown to be the dominant element for specific neurotrophin binding. Using computer graphics models of the human TrkA and TrkC immunoglobulinlike domains as a guide, the residues involved in binding to their respective neurotrophins were mapped by mutational analysis. TrkC primarily utilizes loop EF, between beta-strands E and F, for binding. In contrast, TrkA utilizes the EF loop as well as additional residues, the latter being prime candidates for determining the specificity of TrkA versus TrkC, When selected TrkC and TrkA mutants with reduced binding were expressed on NIH3T3 cells, neurotrophin-induced autophosphorylation was strongly reduced or absent.
引用
收藏
页码:5829 / 5840
页数:12
相关论文
共 64 条
[1]  
BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B
[2]  
BARKER PA, 1993, J BIOL CHEM, V268, P15150
[3]   NEUROTROPHIN-5 - A NOVEL NEUROTROPHIC FACTOR THAT ACTIVATES TRK AND TRKB [J].
BERKEMEIER, LR ;
WINSLOW, JW ;
KAPLAN, DR ;
NIKOLICS, K ;
GOEDDEL, DV ;
ROSENTHAL, A .
NEURON, 1991, 7 (05) :857-866
[4]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[5]  
BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582
[6]   CRYSTAL-STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC [J].
BURMEISTER, WP ;
HUBER, AH ;
BJORKMAN, PJ .
NATURE, 1994, 372 (6504) :379-383
[7]   DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY [J].
CAPON, DJ ;
CHAMOW, SM ;
MORDENTI, J ;
MARSTERS, SA ;
GREGORY, T ;
MITSUYA, H ;
BYRN, RA ;
LUCAS, C ;
WURM, FM ;
GROOPMAN, JE ;
BRODER, S ;
SMITH, DH .
NATURE, 1989, 337 (6207) :525-531
[8]   P75 AND TRK - A 2-RECEPTOR SYSTEM [J].
CHAO, MV ;
HEMPSTEAD, BL .
TRENDS IN NEUROSCIENCES, 1995, 18 (07) :321-326
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   AN ALTERNATIVELY SPLICED FORM OF THE NERVE GROWTH-FACTOR RECEPTOR TRKA CONFERS AN ENHANCED RESPONSE TO NEUROTROPHIN-3 [J].
CLARY, DO ;
REICHARDT, LF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11133-11137